1. Home
  2. MTCH vs LNTH Comparison

MTCH vs LNTH Comparison

Compare MTCH & LNTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Match Group Inc.

MTCH

Match Group Inc.

N/A

Current Price

$44.26

Market Cap

9.6B

Sector

Technology

ML Signal

N/A

Logo Lantheus Holdings Inc.

LNTH

Lantheus Holdings Inc.

N/A

Current Price

$100.60

Market Cap

6.6B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
MTCH
LNTH
Founded
1986
1956
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Programming Data Processing
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.6B
6.6B
IPO Year
2004
2014

Fundamental Metrics

Financial Performance
Metric
MTCH
LNTH
Price
$44.26
$100.60
Analyst Decision
Hold
Buy
Analyst Count
12
6
Target Price
$35.17
$87.00
AVG Volume (30 Days)
3.0M
1.1M
Earning Date
05-05-2026
05-07-2026
Dividend Yield
2.16%
N/A
EPS Growth
17.82
N/A
EPS
1.37
2.91
Revenue
$3,487,197,000.00
$343,374,000.00
Revenue This Year
$2.15
N/A
Revenue Next Year
$3.82
$14.19
P/E Ratio
$32.41
$34.62
Revenue Growth
0.22
3.62
52 Week Low
$28.81
$49.67
52 Week High
$43.47
$111.86

Technical Indicators

Market Signals
Indicator
MTCH
LNTH
Relative Strength Index (RSI) 63.42 43.86
Support Level $29.66 $99.80
Resistance Level N/A $101.43
Average True Range (ATR) 1.10 0.49
MACD 0.04 0.06
Stochastic Oscillator 84.21 12.94

Price Performance

Historical Comparison
MTCH
LNTH

About MTCH Match Group Inc.

Match Group Inc is a provider of online dating products. The company's portfolio of brands includes Tinder, Hinge, Match, Meetic, OkCupid, Pairs, Plenty Of Fish, Azar, BLK, and more, each built to increase its user's likelihood of connecting with others. The company has four operating segments: Tinder, Hinge, Evergreen and Emerging, and Match Group Asia. It generates the majority of its revenue from the Tinder segment.

About LNTH Lantheus Holdings Inc.

Lantheus Holdings Inc is a radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver patient outcomes. The Company classifies its products into Radiopharmaceutical Oncology, Precision Diagnostics, and Strategic Partnerships and Other Revenue. Its products help healthcare professionals Find, Fight and Follow cancer and diseases and are used by physicians and technologists in clinical settings. The Company produces and markets its products in the United States, mainly to hospitals, independent imaging centers and government facilities, and sells outside the United States through direct and third-party distribution relationships and licensing arrangements in Europe, Canada, Australia, Asia-Pacific, Central America and South America.

Share on Social Networks: